1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Carbapenem-based Antibiotics Market – By Type

1.3.2        North America Carbapenem-based Antibiotics Market – By Indication

1.3.3        North America Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4        North America Carbapenem-based Antibiotics Market – By Country

2.           Carbapenem-based Antibiotics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Global Carbapenem-based Antibiotics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America– PEST Analysis

4.3         Expert Opinions

5.           Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1         Drivers

5.1.1        Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2        Increasing Production of Generic Drugs

5.2         Market Restraints

5.2.1        Tedious and Expensive Process of Antibiotic Development

5.3         Market Opportunities

5.3.1        Private and Public Partnerships

5.4         Future Trends

5.4.1        Strategic Advancement for New Antibiotic Identification

5.5         Impact Analysis

6.           Carbapenem-based Antibiotics Market –Regional Analysis

6.1         North America Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

7.           Carbapenem-based Antibiotics Market Analysis – By Type

7.1         Overview

7.2         Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3         Meropenem

7.3.1        Overview

7.3.2        Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Doripenem

7.4.1        Overview

7.4.2        Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Imipenem

7.5.1        Overview

7.5.2        Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Tebipenem

7.6.1        Overview

7.6.2        Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Carbapenem-based Antibiotics Market – By Indication

8.1         Overview

8.2         Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3         Bacterial Meningitis

8.3.1        Overview

8.3.2        Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Acute Pelvic Infections

8.4.1        Overview

8.4.2        Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Respiratory Tract Infections

8.5.1        Overview

8.5.2        Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Intra-abdominal Infections

8.6.1        Overview

8.6.2        Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Carbapenem-based Antibiotics Market – By Distribution Channel

9.1         Overview

9.2         Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Online Pharmacies

9.4.1        Overview

9.4.2        Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Hospital Pharmacies

9.5.1        Overview

9.5.2        Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Carbapenem-based Antibiotics Market –Country Analysis

10.1      North America: Carbapenem-based Antibiotics Market

10.1.1     Overview

10.1.2     North America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3     North America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4     North America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5     North America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6     North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1       US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1       US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2       US: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3       US: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4       US: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2       Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1       Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2       Canada: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3       Canada: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4       Canada: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3       Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1       Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2       Mexico: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3       Mexico: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4       Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11.        Impact of COVID-19 Pandemic on North America Carbapenem-based Antibiotics Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Carbapenem-based Antibiotics Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        COMPANY PROFILES

13.1      ACS Dobfar S.p.A

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Iterum Therapeutics plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      DAEWOONG PHARMACEUTICAL CO.,LTD

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Aurobindo Pharma Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Gland Pharma Limited

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Merck & Co., Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Sumitomo Dainippon Pharma Co., Ltd.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Savior Lifetec

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Pfizer Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Spero Therapeutics

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             North America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3.             North America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             US: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             US: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Canada: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Canada: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Canada: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Mexico: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          Mexico: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Organic Developments in the Carbapenem-based Antibiotics Market

Table 14.          Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 15.          Glossary of Terms, Carbapenem-based Antibiotics Market

LIST OF FIGURES

Figure 1.           Carbapenem-based Antibiotics Market Segmentation

Figure 2.           Carbapenem-based Antibiotics Segmentation, By Country

Figure 3.           North America Carbapenem-based Antibiotics Market Overview

Figure 4.           The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market

Figure 5.           North America Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)

Figure 6.           North America PEST Analysis

Figure 7.           Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints

Figure 8.           North America Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9.           Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

Figure 10.        Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

Figure 16.        Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

Figure 23.        Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27.        North America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 28.        North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

Figure 29.        US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30.        Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 31.        Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32.        Impact Of COVID-19 Pandemic in North American Country Markets